Parameter | Value |
---|---|
Number of patients | 72 |
Female | 41 (56.9) |
Male | 31 (43.1) |
Median age (range) in years | 37 (5–64) |
Median CD4 count (range) in cells/mm3 | 293 (6–196) |
Median plasma viral load (range) in copies/ml | 15,548 (50–73,389) |
ART regimen at time of genotyping | |
 TDF/FTC/EFV | 22 (29.3) |
 TDF/3TC/EFV | 13 (18.1) |
 TDF/3TC/LPV/r | 9 (12.5) |
 ABC/3TC/EFV | 7 (9.7) |
 AZT/3TC/LPV/r | 5 (6.9) |
 TDF/3TC/NVP | 3 (4.2) |
 Othersa | 13 (18.1) |
Time on ART (months) | |
 <24 | 20 (27.8) |
 25–60 | 25 (34.7) |
 >60 | 27 (37.5) |
Clinical stage (CDC) (%) | |
 A: >500 | 14 (19.4) |
 B: 200–500 | 36 (50) |
 C: <200 | 22 (30.6) |
Amplified Genotypes (%) | |
 Subtype C | 65 (94.2) |
 Subtype B | 1 (1.4) |
 Others (K/C, C/B and unclassified) | 3 (4.4) |